SCHEMBL33377988

SCHEMBL33377988

CC(C)c1cnn2c(Nc3ccccn3)cc(Cl)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 11/20 0.42
▸ CDK7 P50613 10/20 0.42
▸ CDK5 Q00535 3/20 0.42
▸ CDK5R1 Q15078 2/20 0.42
▸ DYRK1A Q13627 2/20 0.42
▸ CCNA2 P20248 2/20 0.42
▸ CCNA1 P78396 1/20 0.42
▸ CCNE1 P24864 4/20 0.40
▸ CCNH P51946 4/20 0.40
▸ CDK1 P06493 3/20 0.40
▸ CDK9 P50750 3/20 0.40
▸ CDK6 Q00534 3/20 0.40
▸ MNAT1 P51948 3/20 0.40
▸ CCNT1 O60563 2/20 0.40
▸ CDK4 P11802 2/20 0.40
▸ CCNB1 P14635 2/20 0.40
▸ CCND1 P24385 2/20 0.40
▸ CDK8 P49336 2/20 0.40
▸ GSK3B P49841 2/20 0.40
▸ CHEK1 O14757 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33377934 0.85 CDK2 (0.43) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33378035 0.85 CDK2 (0.40) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33377883 0.85 CDK2 (0.43) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33377958 0.84 CDK7 (0.60) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33377978 0.82 CDK7 (0.48) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33378025 0.81 KDM4E (0.56) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33378032 0.81 CDK2 (0.41) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33377933 0.81 GRM5 (0.43) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL33378019 0.80 CDK2 (0.42) CDK2CDK7CDK5CDK5R1DYRK1A
SCHEMBL19742549 0.79 CDK2 (0.57) CDK2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback